Synthetic C5a receptor agonists: Pharmacology, metabolism and in vivo cardiovascular and hematologic effects
- 24 March 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (6), 1289-1299
- https://doi.org/10.1016/0006-2952(93)90282-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Structure-function studies in a series of carboxyl-terminal octapeptide analogs of anaphylatoxin C5aJournal of Medicinal Chemistry, 1992
- Improvements in the minimum binding sequence of C5a: examination of His-67Journal of Medicinal Chemistry, 1992
- In vitro degradation of endothelin-1 by endopeptidase 24.11 (enkephalinase)Peptides, 1991
- Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase NPeptides, 1991
- C5a-mediated release of interleukin 6 by human monocytesClinical Immunology and Immunopathology, 1990
- Purification and characterization of a new arginine carboxypeptidase in human serumBiochimica et Biophysica Acta (BBA) - General Subjects, 1990
- Basic carboxypeptidases: regulators of peptide hormone activityTrends in Pharmacological Sciences, 1988
- High-level C5a gene expression and recovery of recombinant human C5a fromEscherichia coliInflammation Research, 1987
- Anaphylatoxin Generation in Multisystem Organ FailurePublished by Wolters Kluwer Health ,1984
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJCI Insight, 1970